أخبار حالية

We have launched a new issue of Instituto Bernabeu corporate newsletter “IB Newsletter”. Preimplantational Genetic Diagnosis (PGD) or Preimplantational Genetic Test (PGT)

Grupo Instituto Bernabeu achieves in 2020 a new recognition to its excellency solid policy. The institution has been awarded with the QH** two stars Certificate for the health care quality provided given by the Instituto …

This award values the innovative marketing work, the adaptation capacity, internationalisation and the differentiation between design and communication of the specific pathologies’ treatment.

Instituto Bernabeu’s endocrinologist, Dr Pino Navarro, has taken part of the 9th Ginep Scientific Meeting held in Alicante with the presentation “Pharmacological approach in overweight infertile women.

Instituto Bernabeu’s medical director, doctor Rafael Bernabeu, will address on 12 of November the medical and assistance aspects of the Trans-border Reproductive Medicine.

Loyal to the annual meeting, this 2020 Instituto Bernabeu participates in the Miguel Hernandez University (MHU) 16th Pharmacy Students Congress (CEFA in Spanish).

In this war against the invisible and relentless enemy, Instituto Bernabeu fights with all possible weapons to keep the highest safety and quality standards in all clinics.

Instituto Bernabeu organises next Thursday November the 5th at 17:00H a free and open to all webinar entitled “Pregnancy medical cares in covid times”. Doctor Francisco Sellers, High Risk Pregnancy Unit director in Instituto Bernabeu, …

We have launched a new issue of Instituto Bernabeu corporate newsletter “IB Newsletter”. When the family has just one mom and when two moms form a family.

According to the specialists’ Delphy study, coordinated by Instituto Bernabeu and the UMH’s Community and Reproductive Medicine Chair, there’s a unanimous agreement to promote the reproductive planning need from adolescence and in the media